Celltrion Pharm, Inc.

KOSDAQ 068760.KQ

Celltrion Pharm, Inc. Net Cash Used Provided By Financing Activities for the year ending December 31, 2023: USD -6.11 M

Celltrion Pharm, Inc. Net Cash Used Provided By Financing Activities is USD -6.11 M for the year ending December 31, 2023, a 67.97% change year over year. Net cash used/provided by financing activities are the total cash inflows and outflows related to activities that finance the company’s operations, including debt, equity, and dividends.

Celltrion Pharm, Inc. Net Cash Used Provided By Financing Activities for the year ending December 31, 2022 was USD -19.08 M, a -35.62% change year over year.
Celltrion Pharm, Inc. Net Cash Used Provided By Financing Activities for the year ending December 31, 2021 was USD -14.07 M, a -152.04% change year over year.
Celltrion Pharm, Inc. Net Cash Used Provided By Financing Activities for the year ending December 31, 2020 was USD 27.04 M, a 120.84% change year over year.
Celltrion Pharm, Inc. Net Cash Used Provided By Financing Activities for the year ending December 31, 2019 was USD 12.24 M, a 490.67% change year over year.

Key data

Date	Net Cash Used Provided By Financing Activities	Dividends Paid	Capital Expenditure	Effect Of Forex Changes On Cash

KOSDAQ: 068760.KQ

Celltrion Pharm, Inc.

CEO	Jung-su Seo
IPO Date	Feb. 3, 2006
Location	South Korea
Headquarters	82, 2sandan-ro
Employees	888
Sector	Health Care
Industries Pharmaceuticals Biotechnology Drugstores & Retail Pharmacies

Description

Celltrion Pharm, Inc., a pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea. The company offers hepatotonic, anti-inflammatory, antihistamine, respiratory apparatus, circulary system, digestive and stomachic, hormone/metabolic disease, antibiotic/antimycotic, nutrientia and tonic, immunology, oncology, and other drugs. It serves university hospitals and general pharmacies. Celltrion Pharm Inc. was founded in 1976 and is based in Cheongju, South Korea.

Key trends

Past 5 years